Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension?

Yang, Eugene
May 2011
ACP Journal Club;5/15/2011, Vol. 154 Issue 5, p7
Academic Journal
The article reports on a study which noted the efficacy of hydrochlorothiazide (HCTZ) for reducing ambulatory blood pressure (BP) in patients with hypertension. The study was conducted by researcher F.H. Messerli and colleagues, and was published in a 2011 issue of the "Journal of the American College of Cardiology." The study revealed that low-dose hydrochlorothiazide is too effective as other antihypertensive drugs for reducing ambulatory blood pressure in patients with hypertension.


Related Articles

  • 2011 - Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension? Yang, Eugene // ACP Journal Club;5/15/2011, Vol. 154 Issue 5, p7 

    Question What is the efficacy of hydrochlorothiazide (HCTZ) for reducing ambulatory blood pressure (BP) in patients with hypertension? Review scope Included studies compared HCTZ monotherapy with other antihypertensive drugs in patients with hypertension, had duration >4 weeks, and reported...

  • Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension. Moutzouri, Elisavet; Florentin, Matilda; Elisaf, Moses S.; Mikhailidis, Dimitri P.; Liberopoulos, Evangelos N. // Current Vascular Pharmacology;May2010, Vol. 8 Issue 3, p344 

    Objective: Arterial hypertension is an important risk factor for the development and progression of cardiovascular disease (CVD). The renin angiotensin aldosterone system (RAAS) plays a crucial role in the pathophysiology of hypertension and associated complications. Direct renin inhibitors...

  • Efficacy and sustainability of 24-h blood pressure control: focus on olmesartan-driven products. Verdecchia, Paolo // Hot Topics in Hypertension;2011, Vol. 4 Issue 12, p25 

    Effective and sustained control of blood pressure (BP) is crucial in preventing organ damage and cardiovascular (CV) complications from hypertension. However, only a minority of treated patients with hypertension achieve adequate BP control. This picture is complicated by the inherent...

  • Differential effects of antihypertensive drugs with differing pharmacological properties on the basal ambulatory blood pressure. Sekino, M; Imai, Y; Ohkubo, T; Omae, T // Journal of Human Hypertension;Oct98, Vol. 12 Issue 10, p719 

    To investigate how antihypertensive drugs with different pharmacological properties affect ambulatory blood pressure (BP) the JAPANESE Study Group developed a database of clinic and ambulatory BPs before and after antihypertensive treatment of patients throughout Japan. Drugs evaluated were...

  • Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Lurbe, Empar; Redon, Josep // Pediatric Nephrology;Mar2008, Vol. 23 Issue 3, p341 

    The goal of this commentary is to review the most relevant topics concerning the clinical utility of ambulatory blood pressure (BP) monitoring, such as the state of the art “reference BP values”, the importance of the discrepant situations between office and ambulatory BP (white-coat...

  • Resistant hypertension: a practical clinical approach. Muxfeldt, E S; de Souza, F; Salles, G F // Journal of Human Hypertension;Nov2013, Vol. 27 Issue 11, p657 

    Resistant hypertension (RH) is defined as an uncontrolled office blood pressure (BP) despite the use of at least three antihypertensive drugs. With an increasing prevalence, RH implies in a very high cardiovascular risk and needs a careful clinical approach, aiming to control BP and to reduce...

  • Blood Pressure Monitoring and Hypertension.  // Current Medical Literature: Cardiology;2010, Vol. 29 Issue 2, p39 

    The article presents clinical reviews on medical topics covering hypertension. It cites the results of a meta-analysis which determined whether using a fixed-dose combination (FDC) of antihypertensive tablets is more beneficial over separate prescription of the two component drugs. It cites a...

  • Valsartan/Hydrochlorothiazide: A Review of its Pharmacology, Therapeutic Efficacy and Place in the Management of Hypertension. Wellington, Keri; Faulds, Diana M. // Drugs;2002, Vol. 62 Issue 13, p1983 

    The combination of valsartan [an angiotensin II type 1 (AT[sub 1]) receptor blocker] and hydrochlorothiazide (a thiazide diuretic), administered once daily, has been evaluated in the treatment of patients with hypertension in clinical trials ranging in duration from 8 weeks to 3 years. These...

  • Ambulatory blood pressure lowering efficacy of HCTZ inferior to other drug classes.  // Formulary;Apr2011, Vol. 46 Issue 4, p112 

    The article discusses a report in the "Journal of the American College of Cardiology," in which investigators question the frequent use of the thiazide diuretic drug, hydrochlorothiazide (HCTZ), to treat hypertension. According to the report, HCTZ is the most commonly prescribed...


Read the Article


Sign out of this library

Other Topics